Pulmonx (LUNG) Change in Account Payables (2019 - 2025)
Pulmonx (LUNG) reported Change in Account Payables of $121000.0 for Q3 2025, down 91.02% year-over-year from $1.3 million in Q3 2024, and down 94.35% on a QoQ basis from $2.1 million in Q2 2025.
Pulmonx (LUNG) has 7 years of Change in Account Payables data on file, last reported at $121000.0 in Q3 2025.
- Quarterly Change in Account Payables fell 91.02% year-over-year to $121000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $2.1 million (up 61.41% YoY) and the FY2024 annual result came in at $2.3 million, up 760.29% from the prior year.
- Change in Account Payables eased to $121000.0 in Q3 2025 per LUNG's latest filing, from $2.1 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.6 million in Q3 2021 and bottomed at -$2.8 million in Q4 2021.
- The 5-year median for Change in Account Payables is $121000.0 (2025), against an average of $264894.7.
- The widest annual swing landed in 2022, when Change in Account Payables plunged 2111.11%; it then surged 42900.0% in 2025.
- Tracing LUNG's Change in Account Payables over 5 years: stood at -$2.8 million in 2021, then soared by 70.54% to -$830000.0 in 2022, then slumped by 104.58% to -$1.7 million in 2023, then surged by 58.78% to -$700000.0 in 2024, then soared by 117.29% to $121000.0 in 2025.
- Per Business Quant, the three latest LUNG Change in Account Payables figures stand at $121000.0 (Q3 2025), $2.1 million (Q2 2025), and $505000.0 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 56.90 Mn |
| 10 | Pulmonx | 67.30 Mn | -2.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 121,000.00 |
| Sep 30, 2025 | 121,000.00 |
| Jun 30, 2025 | 2.14 Mn |
| Jun 30, 2025 | 2.14 Mn |
| Mar 31, 2025 | 505,000.00 |
| Mar 31, 2025 | 505,000.00 |
| Dec 31, 2024 | -700,000.00 |
| Dec 31, 2024 | -700,000.00 |
| Sep 30, 2024 | 1.35 Mn |
| Sep 30, 2024 | 1.35 Mn |
| Jun 30, 2024 | -5,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Mar 31, 2024 | 1.64 Mn |
| Mar 31, 2024 | 1.64 Mn |
| Dec 31, 2023 | -1.70 Mn |
| Dec 31, 2023 | -1.70 Mn |
| Sep 30, 2023 | 1.00 Mn |
| Sep 30, 2023 | 1.00 Mn |
| Jun 30, 2023 | -518,000.00 |
| Jun 30, 2023 | -518,000.00 |
| Mar 31, 2023 | 868,000.00 |
| Mar 31, 2023 | 868,000.00 |
| Dec 31, 2022 | -830,000.00 |
| Dec 31, 2022 | -830,000.00 |
| Sep 30, 2022 | 15,000.00 |
| Sep 30, 2022 | 15,000.00 |
| Jun 30, 2022 | -199,000.00 |
| Jun 30, 2022 | -199,000.00 |
| Mar 31, 2022 | 1.26 Mn |
| Mar 31, 2022 | 1.26 Mn |
| Dec 31, 2021 | -2.82 Mn |
| Dec 31, 2021 | -2.82 Mn |
| Sep 30, 2021 | 2.61 Mn |
| Sep 30, 2021 | 2.61 Mn |
| Jun 30, 2021 | -9,000.00 |
| Jun 30, 2021 | -9,000.00 |
| Mar 31, 2021 | 302,000.00 |
| Mar 31, 2021 | 302,000.00 |
| Dec 31, 2020 | 758,000.00 |
| Dec 31, 2020 | 758,000.00 |
| Sep 30, 2020 | 603,000.00 |
| Sep 30, 2020 | 603,000.00 |
| Jun 30, 2020 | -606,000.00 |
| Jun 30, 2020 | -606,000.00 |
| Mar 31, 2020 | -163,000.00 |
| Mar 31, 2020 | -163,000.00 |
| Dec 31, 2019 | 375,000.00 |
| Dec 31, 2019 | 375,000.00 |